Amyotrophic lateral sclerosis - ALS: progression of the disease in diagnosed patients

• Autor(a) principal: Diniz, Ana Beatriz Rangel
• Data de Publicação: 2022
• Outros Autores: Passos, Marco Aurélio Ninômia
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista JRG de Estudos Acadêmicos
• Texto Completo: http://revistajrg.com/index.php/jrg/article/view/404
• topic: Esclerose Lateral Amiotrófica; Progressão da Esclerose Lateral Amiotrófica; Enfermagem na Esclerose Lateral Amiotrófica; Terapêutica na ELA; Fatores de risco ELA; Diagnóstico da Esclerose Lateral Amiotrófica

Objective: Dissert about the progression of Amyotrophic Lateral Sclerosis - ALS in diagnosed patients and discourse about the nurse's role in ALS’s therapy. Methods: The study is about a bibliographic integrative revision, between 2017-2022, through research in the electronic data base of the Scientific Electronic Library Online (Scielo), PubMed, BVS and Lilacs. Results: Twenty-six articles were used in this article, the relation between the content of the article and the theme determined in this article was crucial for the elaboration during the dissertation, by showing the most important information and the conclusion of several authors, divided in six categories: The development of the disease; Risk factors; Diagnosis; Symptomatology and its complications; Therapy; and the nurse’s role in ALS. Conclusion: The study allowed purchase knowledge about the disease, although it is still in constant discovery. The treatment of the pathology occurs through palliative care, planning the interventions according to the patient’s condition, with the objective to provide quality of life for the patient, the patient’s family members and the patients' caregivers. The Riluzol was the most effective medication in the treatment of ALS, increasing the survival and assuaging the symptoms. Beyond that, some risk factors for the development of the disease were pointed out. About the nurse’s role in ALS, it was set that their role is very important during the progression of the disease's course and the pathology’s treatment of the diagnosed patient with ALS.